BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25

• Press Releases

  bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung

  August 18, 2026

   · 

  6 min read
• Press Releases

  Enveda Reports Positive Phase 1 Results for ENV-308, the First Pill Designed From the Chemistry of Exercise

  August 18, 2026

   · 

  8 min read
• Press Releases

  858 Therapeutics Announces FDA Fast Track Designation for PARG Inhibitor ETX-19477 for the Treatment of Patients with BRCA-Mutated, HR+/HER2- Unresectable or Metastatic Breast Cancer

  August 18, 2026

   · 

  2 min read
• 

  Dermatology

  LEO adds to dermatology portfolio with $435M deal for late-stage rare disease drug

  This is the third recent acquisition conducted by Denmark’s LEO Pharma in medical dermatology, a portfolio that marked 12% growth in the first half of the year.

  August 18, 2026

   · 

  1 min read

   · 

  Annalee Armstrong
• 

  Manufacturing

  Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars

  The initial batch of biosimilars includes copies of Amgen, Eli Lilly and GSK drugs that collectively generate billions of dollars in annual revenues.

  August 18, 2026

   · 

  2 min read

   · 

  Nick Paul Taylor
• Press Releases

  Akari Therapeutics Builds Momentum for AKTX-101 with Compelling Urothelial Cancer Data Supporting Differentiated ADC Strategy

  August 18, 2026

   · 

  9 min read
• Press Releases

  BioPorto activates the first US clinical site as part of the ProNephro AKI® U.S. Adult Urine NGAL Validation Study.

  August 18, 2026

   · 

  4 min read
• Press Releases

  Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration

  August 18, 2026

   · 

  10 min read
• Press Releases

  Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP

  August 18, 2026

   · 

  5 min read
• Press Releases

  Vivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India’s Nuclear Regulatory Authority for International Manufacturing Center

  August 18, 2026

   · 

  5 min read